InBrain Neuroelectronics announced today that it closed a Series B financing round with proceeds totaling $50 million. The Barcelona, Spain-based company also secured additional funding and support from Merck KGaA. This goes toward the clinical development of its technology in Merck KGaA’s therapeutic areas of interest. This boosts the translation of the company’s platform to human use, expanding it across both central and peripheral nervous system applications.
InBrain Neuroelectronics raises $50M Series B to support BCI
